Amgen second quarter profit dips, sales rise 20% Investing.com Amgen second quarter profit dips, sales rise 20%. Amgen (AMGN) 1 month
Tango Therapeutics: Amgen Missteps Devalue PRMT5 Candidates Ahead Of Critical Data Seeking Alpha 1 week
How This Amgen Rival Is Taking On The Company’s $28 Billion Acquisition Investor's Business Daily 1 week
Amgen Inc. (AMGN) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) Seeking Alpha 2 weeks
The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race Investor's Business Daily 3 weeks
Why Biotech Giant Amgen Stands A Chance Of Taking On Novo, Lilly In Obesity Investor's Business Daily 1 month
Novartis Dives After Handing Amgen, Bristol — And Their Rivals — A Key Victory Investor's Business Daily 2 months
Amgen Inc. (AMGN): Hedge Funds Are Bullish on This Blue Chip Dividend Stock Now Insider Monkey 2 months
Amgen (AMGN) Stock Fell After Some Concerns Regarding The Released Clinical Data Insider Monkey 3 months
Amgen Inc. (AMGN) Goldman Sachs 45th Annual Global Healthcare Conference Transcript Seeking Alpha 3 months